Back to Duquesne Family Office LLC Duquesne Family Office LLC

NAMSNAMS
8 quarters

Position history for Duquesne Family Office LLCDuquesne Family Office LLC's holdings in NEWAMSTERDAM PHARMA COMPANY

Yes. Duquesne Family Office holds 3,070,146 shares of NAMS (Newamsterdam Pharma), worth $104M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Duquesne Family Office has held NAMS since Q3 2024, across 8 quarterly 13F filings. NAMS is 2.0% of Duquesne Family Office's reported 13F portfolio.

Current Value

$104M

Current Shares

3.1M

Total Value Change

+$99.3M

Total Shares Change

+2.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
3.1M
0.0%
$104M2.0%$33.89
0
2026-Q1
Unchanged
3.1M
0.0%
$98.3M2.9%$32.01
0
2025-Q4
Increased
3.1M
+59.6%
$107.7M2.4%$35.08
74
2025-Q3
Increased
1.9M
+131.2%
$54.7M1.3%$28.44
75
2025-Q2
Increased
832,175
+4.0%
$15.1M0.4%$18.11
35
2025-Q1
Increased
800,360
+178.3%
$16.4M0.5%$20.47
65
2024-Q4
Unchanged
287,535
0.0%
$7.4M0.2%$25.70
0
2024-Q3
New
287,535
-
$4.8M0.2%$16.60
45

Other major holders of NAMS: Capital World Investors, FMR LLC, RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used